Amdocs (NASDAQ:DOX) Director Purchases $100,800.00 in Stock

Amdocs Limited (NASDAQ:DOX – Get Free Report) Director Yvette Kanouff acquired 2,400 shares of the company’s stock in a transaction that occurred on Monday, November 9th. The stock was bought at an average price of $42.00 per share, with a total value of $100,800.00. Following the acquisition, the director directly owned 26,600 shares of the company’s stock, valued at $1,117,200. The trade was a 9.92% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Amdocs Trading Up 2.8%

NASDAQ:DOX traded up $1.22 during mid-day trading on Thursday, hitting $44.34. The company had a trading volume of 1,086,395 shares, compared to its average volume of 1,315,788. The firm has a market cap of $4.79 billion, a P/E ratio of 9.49, a P/E/G ratio of 1.35 and a beta of 0.42. The business’s fifty day moving average is $58.25 and its two-hundred day moving average is $61.37. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.94 and a current ratio of 0.94. Amdocs Limited has a fifty-two week low of $39.96 and a fifty-two week high of $84.95.

Amdocs (NASDAQ:DOX – Get Free Report) last released its quarterly earnings results on Tuesday, November 3rd. The technology company reported $1.98 EPS for the quarter, hitting analysts’ consensus estimates of $1.98. The company had revenue of $1.19 billion for the quarter, compared to analyst estimates of $1.19 billion. Amdocs had a return on equity of 20.81% and a net margin of 10.59%. Amdocs’s revenue was up 3.8% compared to the same quarter last year. During the same quarter last year, the firm posted $1.83 earnings per share. As a group, research analysts expect that Amdocs Limited will post 5.82 earnings per share for the current year.

Amdocs Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 29th. Stockholders of record on Thursday, December 31st will be given a dividend of $0.5690 per share. The ex-dividend date of this dividend is Thursday, December 31st. This represents a $2.28 annualized dividend and a dividend yield of 5.1%. Amdocs’s dividend payout ratio is currently 48.61%.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the stock. First Trust Advisors LP grew its stake in shares of Amdocs by 18.7% in the third quarter. First Trust Advisors LP now owns 1,637,842 shares of the technology company’s stock valued at $93,652,000 after buying an additional 258,098 shares in the last quarter. Advisors Asset Management Inc. bought a new stake in Amdocs during the third quarter worth $40,432,000. Composition Wealth LLC acquired a new stake in Amdocs in the third quarter valued at $309,000. Voya Investment Management LLC lifted its stake in Amdocs by 155.6% in the third quarter. Voya Investment Management LLC now owns 28,213 shares of the technology company’s stock valued at $1,613,000 after acquiring an additional 17,173 shares during the last quarter. Finally, Public Sector Pension Investment Board bought a new position in shares of Amdocs in the 3rd quarter valued at about $3,281,000. Institutional investors and hedge funds own 92.02% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently weighed in on DOX shares. Wall Street Zen lowered shares of Amdocs from a “buy” rating to a “hold” rating in a research note on Saturday, November 7th. Oppenheimer lowered shares of Amdocs from an “outperform” rating to a “market perform” rating in a research report on Wednesday, November 4th. Weiss Ratings upgraded shares of Amdocs from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, October 23rd. Stifel Nicolaus decreased their target price on shares of Amdocs from $71.00 to $46.00 and set a “buy” rating for the company in a research report on Wednesday, November 4th. Finally, Zacks Research cut shares of Amdocs from a “hold” rating to a “strong sell” rating in a research report on Monday. Two investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, Amdocs has an average rating of “Hold” and a consensus target price of $69.00.

Get Our Latest Stock Analysis on Amdocs

Key Headlines Impacting Amdocs

Here are a few of the latest headlines about DOX:

  • Positive Sentiment: Two directors disclosed purchases on November 10: Veronique Morali bought 134 shares and John Anthony Macdonald bought 1,000 shares, at average prices of $41.31 and $41.63. The buying may signal confidence, though the transactions were relatively small. Morali SEC filing Macdonald SEC filing
  • Negative Sentiment: Multiple law firms have announced investigations into potential securities claims, citing allegations that Amdocs may have issued materially misleading business information. These are investigations, not findings of wrongdoing, but they could add reputational and legal uncertainty. Pomerantz investigation notice Rosen investigation notice
  • Negative Sentiment: The central concern remains Amdocs’ fiscal 2027 outlook, reportedly weakened by an escalating T-Mobile dispute. The resulting disappointment was associated with a roughly 30% one-session share decline on November 4, despite quarterly results being in line with expectations. Levi & Korsinsky notice

About Amdocs

(Get Free Report)

Amdocs provides software and services to communications and media companies. Its offerings include business and operational support systems for billing, customer management, service delivery and network operations, as well as cloud and digital solutions that help clients modernize their businesses and improve customer experiences. Founded in 1982, Amdocs serves communications and media providers in markets around the world. The company is headquartered in the St. Louis, Missouri, area and is led by President and Chief Executive Officer Shuky Sheffer.

Featured Stories

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.